Intrinsic molecular subtypes of breast cancers categorized as HER2-positive using an alternative chromosome 17 probe assay

The 2013 update of the American Society of Clinical Oncology-College of American Pathologists (ASCO-CAP) human epidermal growth factor receptor 2 (HER2) testing guidelines recommend using an alternative chromosome 17 probe assay to resolve HER2 results determined to be equivocal by immunohistochemis...

Descripción completa

Detalles Bibliográficos
Autores principales: Desai, Neelam V., Torous, Vanda, Parker, Joel, Auman, James T., Rosson, Gary B., Cruz, Cassandra, Perou, Charles M., Schnitt, Stuart J., Tung, Nadine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042281/
https://www.ncbi.nlm.nih.gov/pubmed/29996866
http://dx.doi.org/10.1186/s13058-018-1005-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042281/
https://www.ncbi.nlm.nih.gov/pubmed/29996866
http://dx.doi.org/10.1186/s13058-018-1005-z

Ejemplares similares